Impact of Combined Heart and Lung Transplantation on Bronchiolitis Obliterans Syndrome, Cardiac Allograft Vasculopathy, and Long-Term Survival

There has been continuous improvement in survival after heart transplantation (HTx) and lung transplantation (LTx), facilitated by developments regarding surgical procedures and postoperative immunosuppressive regimens.1,2 However, primary graft dysfunction remains a significant source of early and late morbidity and mortality among transplant recipients.1-4 Such conditions include bronchiolitis obliterans syndrome (BOS) in LTx recipients and coronary allograft vasculopathy (CAV) in HTx recipients.

Source: The Journal of Heart and Lung Transplantation - August 26, 2019 Category: Transplant Surgery Authors: Takeshi Kitai, Toshihiro Okamoto, Chisato Miyakoshi, Hiromichi Niikawa, Paulino A. Alvarez, Chayakrit Krittanawong, Andrew Xanthopoulos, Kenneth R McCurry Tags: Original Clinical Science Source Type: research